Related Experiment Video
Updated: Jun 12, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Rosuvastatin-induced thrombocytopenia
Ioannis Vrettos1, Sotiris Papageorgiou, Christina Economopoulou
1Second Department of Internal Medicine, Propaedeutic, University of Athens, Medical School, Attikon University General Hospital, Haidari, Athens, Greece.
Abstract:
Rosuvastatin, a statin indicated for patients with primary hypercholesterolemia, mixed dyslipidemia and familial hypercholesterolemia, is well tolerated by most patients. Its most common adverse effects are gastrointestinal derangement, muscle aches and hepatitis. One rare complication of statin treatment is severe thrombocytopenia. The case of a 65-year-old patient who developed severe thrombocytopenia while on rosuvastatin is presented, in addition to a review of the literature.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care
Drug toxicity: Idiosyncratic Reactions
Pharmacokinetics: Drug–Drug Interactions
Therapeutic Drug Monitoring: Affecting Factors
